trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Ganglioneuroma D005729 2 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Duffy S et al. Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:27551064
Hrgovic I et al. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. 2016 BMC Cancer pmid:27716272
Sobue S et al. Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel. 2016 Biochem. Biophys. Res. Commun. pmid:27687545
Zhang Q et al. Trichostatin A protects against intestinal injury in rats with acute liver failure. 2016 J. Surg. Res. pmid:27620992
Somanna NK et al. Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation. 2016 Hypertens. Res. pmid:27278287
Kang HR et al. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells. 2016 Oncol. Rep. pmid:27277338
Agudelo M et al. Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat. 2016 PLoS ONE pmid:27249803
Allgayer J et al. Widespread transcriptional gene inactivation initiated by a repair intermediate of 8-oxoguanine. 2016 Nucleic Acids Res. pmid:27220469
Calvert S et al. A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans. 2016 Aging Cell pmid:26676933
Zhang Q et al. Trichostatin A inhibits inflammation in phorbol myristate acetate‑induced macrophages by regulating the acetylation of histone and/or non‑histone proteins. 2016 Mol Med Rep pmid:26647731
Kikuchi M et al. Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. 2016 Oncotarget pmid:26646320
Vargas-López V et al. Histone deacetylase inhibition abolishes stress-induced spatial memory impairment. 2016 Neurobiol Learn Mem pmid:27544851
Pang X et al. Knockdown of Rad9A enhanced DNA damage induced by trichostatin A in esophageal cancer cells. 2016 Tumour Biol. pmid:26264615
Sanaei M et al. Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells 2017 Asian Pac. J. Cancer Prev. pmid:29286617
Takamatsu G et al. Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons. 2017 Biochem. Biophys. Res. Commun. pmid:27939885
Aquea F et al. Chemical inhibition of the histone acetyltransferase activity in Arabidopsis thaliana. 2017 Biochem. Biophys. Res. Commun. pmid:27993678
Shinde V et al. Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox and STOP-Tox tests. 2017 Arch. Toxicol. pmid:27188386
Yeakley JM et al. A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. 2017 PLoS ONE pmid:28542535
Choiniere J et al. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. 2017 Mol. Pharmacol. pmid:28003426
Porter NJ et al. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors. 2017 Proc. Natl. Acad. Sci. U.S.A. pmid:29203661
Bagheri-Hosseinabadi Z et al. Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor. 2017 Biomed Eng Online pmid:29169361
Lam YM et al. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo. 2017 Int. J. Hematol. pmid:27531147
Good KV et al. Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity. 2017 Epigenetics pmid:29099289
Wu Y et al. Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway. 2017 J Diabetes Res pmid:28191472
Vanneste M et al. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells. 2017 Mol. Cell. Endocrinol. pmid:28137613
Wang XJ et al. Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells. 2017 Cell Rep pmid:28122243
Cao Z et al. TSA and BIX-01294 Induced Normal DNA and Histone Methylation and Increased Protein Expression in Porcine Somatic Cell Nuclear Transfer Embryos. 2017 PLoS ONE pmid:28114389
Chen L et al. PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer. 2017 Oncotarget pmid:28060760
Campo VA Comparative effects of histone deacetylases inhibitors and resveratrol on Trypanosoma cruzi replication, differentiation, infectivity and gene expression. 2017 Int J Parasitol Drugs Drug Resist pmid:28038431
Alqinyah M et al. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity. 2017 Mol. Pharmacol. pmid:28031332
Mazzio EA and Soliman KF HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. 2017 Cancer Genomics Proteomics pmid:28031235
Duan H et al. The effect of histone deacetylase inhibition on the expression of P-glycoprotein in human placental trophoblast cell lines. 2017 Placenta pmid:28012453
Mengel A et al. Nitric Oxide Modulates Histone Acetylation at Stress Genes by Inhibition of Histone Deacetylases. 2017 Plant Physiol. pmid:27980017
Wittayarat M et al. Epigenetic modulation on cat-cow interspecies somatic cell nuclear transfer embryos by treatment with trichostatin A. 2017 Anim. Sci. J. pmid:27506538
Hrgovic I et al. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism. 2017 Exp. Dermatol. pmid:27487811
Green AL et al. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. 2017 Neuropharmacology pmid:28743636
Zapletal O et al. Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. 2017 Arch. Toxicol. pmid:27830268
Hartl M et al. Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in . 2017 Mol. Syst. Biol. pmid:29061669
Wei ZQ et al. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation. 2017 World J. Gastroenterol. pmid:28974891
Xie C et al. In vitro analysis of factors influencing expression as potential determinants of interindividual variation. 2017 Pharmacol Res Perspect pmid:28357125
Guo Y et al. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway. 2017 Int. J. Mol. Med. pmid:28849190
Tao LL et al. TSA increases C/EBP‑α expression by increasing its lysine acetylation in hepatic stellate cells. 2017 Mol Med Rep pmid:28849174
Kudo K et al. Biosynthetic Origin of the Hydroxamic Acid Moiety of Trichostatin A: Identification of Unprecedented Enzymatic Machinery Involved in Hydroxylamine Transfer. 2017 J. Am. Chem. Soc. pmid:28497964
Lin W et al. Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor γ reduces the progression of chronic kidney disease. 2017 Kidney Int. pmid:28416226
Zhang XF et al. Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3). 2017 Int J Nanomedicine pmid:29075115
Simões-Pires CA et al. Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS. 2017 J Vis Exp pmid:28829415
Ngwa CJ et al. Transcriptional Profiling Defines Histone Acetylation as a Regulator of Gene Expression during Human-to-Mosquito Transmission of the Malaria Parasite . 2017 Front Cell Infect Microbiol pmid:28791254
Wang SC et al. Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1‑survivin downregulation at the late phase of treatment. 2017 Oncol. Rep. pmid:28713892
Hichino A et al. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. 2017 J. Biol. Chem. pmid:28057758
Gilardini Montani MS et al. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells. 2017 Cell Oncol (Dordr) pmid:28160167